{"gene":"SLC16A3","run_date":"2026-04-28T20:42:07","timeline":{"discoveries":[{"year":2006,"finding":"MCT4 (SLC16A3) expression is transcriptionally upregulated by hypoxia through HIF-1α binding to hypoxia-response elements in the MCT4 promoter; mutation of a specific HRE (site 2) abolished the hypoxic response, and gel-shift/supershift assays confirmed direct HIF-1α binding.","method":"Promoter-luciferase reporter assays, deletion and mutation analysis, gel-shift and supershift analysis with nuclear extracts from hypoxic HeLa cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods (reporter assay, deletion mapping, mutagenesis, EMSA supershift) in a single rigorous study","pmids":["16452478"],"is_preprint":false},{"year":2000,"finding":"CD147 specifically interacts with MCT4 (and MCT1) via its transmembrane and cytoplasmic domains, and this interaction is required for proper cell-surface expression of MCT4; co-transfection of CD147 with MCT4 enabled plasma membrane localization and transport activity, whereas MCT4 alone accumulated in a perinuclear compartment.","method":"Co-immunoprecipitation, chemical cross-linking, CD2-CD147 chimera studies, co-transfection in mammalian cell lines, immunofluorescence co-localization, functional transport assay","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — reciprocal co-IP, cross-linking, chimera mapping, reconstitution of transport activity; replicated across multiple labs","pmids":["10921872"],"is_preprint":false},{"year":2019,"finding":"MCT4 is a high-affinity lactate transporter with Km ~0.7–1.7 mM for lactate (not ~30–40 mM as previously reported), and also transports pyruvate with Km ~4.2 mM. Previous high Km estimates were biased by pH-regulatory mechanisms. CRISPR/Cas9 deletion confirmed MCT4 as the dominant lactate transporter in MDA-MB-231 cells and macrophages.","method":"FRET sensors (Laconic, Pyronic) for real-time lactate/pyruvate dynamics, CRISPR/Cas9-mediated MCT4 deletion, pH-sensitive dye (BCECF), recombinant MCT4 expression in HEK293 cells, numerical simulation","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including genetic knockout and recombinant reconstitution with rigorous kinetic analysis","pmids":["31719150"],"is_preprint":false},{"year":2000,"finding":"MCT4 localizes exclusively to the sarcolemmal membrane in skeletal muscle (not mitochondria), whereas MCT1 is found in both sarcolemmal and mitochondrial membranes, indicating distinct subcellular roles; MCT4 also has a significant intracellular pool in triads and sarcoplasmic reticulum.","method":"Subcellular fractionation (plasma membrane, triads, T-tubules, sarcoplasmic reticulum, intracellular membrane fractions), Western blotting with isoform-specific antibodies","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 — direct fractionation with isoform-specific antibodies; single lab","pmids":["10827010"],"is_preprint":false},{"year":2003,"finding":"In basigin (CD147)-null mice, MCT4 protein is severely reduced in the neural retina despite normal mRNA levels, confirming that CD147/basigin is required post-transcriptionally for MCT4 protein stability and/or membrane targeting in vivo.","method":"Immunofluorescence microscopy, Western blot, and RT-PCR in Bsg−/− knockout mice","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with multiple orthogonal readouts (protein vs. mRNA levels)","pmids":["12601063"],"is_preprint":false},{"year":2011,"finding":"MCT4 mediates lactate/H+ efflux and is required for tumor glycolytic flux; zinc-finger nuclease knockout of MCT4 in LS174T colon adenocarcinoma cells reduced glycolytic flux and tumor growth, and MCT4 re-expression in respiration-deficient cells restored tumorigenicity.","method":"Zinc finger nuclease-mediated MCT4 knockout, inducible shRNA silencing, AR-C155858 MCT1/2 pharmacological inhibition, tumor xenograft growth assay, lactate secretion measurement","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 — genetic knockout and re-expression rescue, multiple cell line and in vivo validation","pmids":["21930917"],"is_preprint":false},{"year":2013,"finding":"MCT4 silencing in renal clear cell carcinoma impairs lactate secretion, causes intracellular acidosis, reduces intracellular ATP, and induces cell-cycle arrest and apoptosis, establishing MCT4 as a functional regulator of the Warburg effect in this cancer.","method":"Genome-wide RNAi screen, siRNA knockdown in 8 ccRCC lines, lactate secretion assay, intracellular pH measurement, ATP quantification, flow cytometry (cell cycle and apoptosis)","journal":"The Journal of pathology","confidence":"High","confidence_rationale":"Tier 2 — genome-wide functional screen plus mechanistic validation with multiple phenotypic readouts across multiple cell lines","pmids":["22362593"],"is_preprint":false},{"year":2013,"finding":"SLC16A3/MCT4 promoter DNA methylation inversely regulates MCT4 expression in renal clear cell carcinoma; promoter activity assays in RCC cell lines confirmed that DNA methylation directly suppresses MCT4 transcription.","method":"Bisulfite sequencing, TCGA methylation analysis, promoter activity (luciferase) assays in RCC cell lines, mRNA and protein quantification","journal":"Clinical cancer research","confidence":"Medium","confidence_rationale":"Tier 2 — promoter reporter assays plus correlation validated in three independent cohorts; mechanism (writer) not fully defined","pmids":["23881922"],"is_preprint":false},{"year":2019,"finding":"Under hypoxia, NF-κB (RelA/p65) represses ZBTB7A (encoding the repressor FBI-1), which normally binds FBI-1-response elements and HREs in the SLC16A3 promoter to suppress MCT4 transcription; loss of FBI-1 under hypoxia de-represses SLC16A3, while HIF-1α simultaneously activates it via an HRE.","method":"Transient transfection and luciferase reporter assays of SLC16A3 promoter, oligonucleotide pulldown, ChIP assays, siRNA knockdown of ZBTB7A and HIF-1α, NF-κB overexpression in colon cancer cells","journal":"Biochimica et biophysica acta. Gene regulatory mechanisms","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (ChIP, reporter, pulldown) but single lab","pmids":["31271899"],"is_preprint":false},{"year":2013,"finding":"Hypoxia (1% O2 or DMOG treatment) induces MCT4 expression in cultured cortical astrocytes via HIF-1α; siRNA knockdown of HIF-1α prevented MCT4 induction, and MCT4 induction was necessary for increased lactate transport capacity and astrocyte survival under prolonged hypoxia.","method":"siRNA against HIF-1α, prolyl hydroxylase inhibitor DMOG, siRNA against MCT4, lactate release measurement, astrocyte survival assay under 1% O2","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA epistasis (HIF-1α → MCT4 → lactate transport) with functional survival readout; single lab","pmids":["24375723"],"is_preprint":false},{"year":2011,"finding":"Nitric oxide induces MCT4 expression in astrocytes at mRNA and protein levels via a cGMP-independent transcriptional mechanism, increasing astrocytic lactate transport capacity; siRNA against MCT4 prevented the NO-induced increase in lactate transport.","method":"NO donor treatment, cGMP analog and guanylate cyclase inhibitor controls, siRNA against MCT4, lactate transport measurement, 24-h cumulative lactate release assay","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological epistasis plus siRNA rescue with functional readout; single lab","pmids":["21901758"],"is_preprint":false},{"year":2015,"finding":"MCT4 histidine residue His382 in the extracellular loop is essential for pH regulation of MCT4-mediated lactate transport; H382A mutation abolished pH-dependent activity, and chemical modification of histidines (DEPC) removed pH regulation without fully inactivating transport.","method":"Site-directed mutagenesis (H382A), Xenopus oocyte expression system, DEPC chemical modification, Zn2+ inhibition, lactate uptake assay at varied pH","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1 — active-site mutagenesis with functional reconstitution in Xenopus oocyte system","pmids":["25919709"],"is_preprint":false},{"year":2016,"finding":"Diclofenac is a non-competitive inhibitor of MCT4-mediated lactate transport with Ki ~20 µM, as demonstrated in Caco-2 cells (endogenously expressing MCT4) and validated in the Xenopus oocyte expression system.","method":"Lactate uptake inhibition assay in Caco-2 cells, kinetic analysis (inhibition constant), Xenopus oocyte expression system with MCT4","journal":"Drug metabolism and pharmacokinetics","confidence":"Medium","confidence_rationale":"Tier 1-2 — kinetic characterization in two systems (endogenous and heterologous expression); single lab","pmids":["27236641"],"is_preprint":false},{"year":2018,"finding":"Syrosingopine is a dual MCT1/MCT4 inhibitor (60-fold higher potency on MCT4) that prevents lactate and H+ efflux; MCT4 inhibition causes intracellular lactate accumulation leading to end-product inhibition of lactate dehydrogenase, reducing NAD+ regeneration from NADH and blocking glycolysis, which is synthetically lethal with metformin.","method":"Pharmacological inhibition with syrosingopine, intracellular lactate measurement, NAD+/NADH ratio, ATP measurement, exogenous NAD+ rescue, metformin combination lethality assay in cancer cells","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 — mechanistic pathway established with pharmacological inhibition, metabolite rescue, and multiple orthogonal readouts","pmids":["30540938"],"is_preprint":false},{"year":2019,"finding":"MCT4 in colonic epithelial cells promotes NF-κB p65 nuclear translocation and enhances NF-κB-CBP interaction while dissolving the CREB-CBP complex, thereby increasing IL-6 transcription and reducing CREB-mediated ZO-1 expression, disrupting intestinal barrier function.","method":"Lentiviral MCT4 overexpression, luciferase reporter assays for IL-6 and ZO-1 promoters, co-immunoprecipitation of NF-κB-CBP and CREB-CBP complexes, ChIP assay, in vivo colitis model with MCT4 inhibitor CHC","journal":"Cell proliferation","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods (Co-IP, ChIP, reporter, in vivo) but single lab; non-metabolic MCT4 function","pmids":["31418947"],"is_preprint":false},{"year":2023,"finding":"LKB1 loss enhances lactate production and secretion via MCT4, leading to M2 macrophage polarization and hypofunctional T cells; MCT4 knockout reversed immunotherapy resistance to PD-1 blockade in syngeneic murine models, and exogenous lactate recapitulated immunosuppression reversed by MCT4 knockdown.","method":"MCT4 knockout in murine tumor models, syngeneic PD-1 blockade tumor experiments, single-cell RNA profiling, GPR81 blockade, exogenous lactate treatment, MCT4 knockdown","journal":"Cancer cell","confidence":"High","confidence_rationale":"Tier 2 — genetic KO, rescue with exogenous lactate, GPR81 blockade epistasis, in vivo syngeneic immunotherapy model; multiple orthogonal approaches","pmids":["37327788"],"is_preprint":false},{"year":2024,"finding":"MCT4 deficiency in macrophages results in intracellular lactate accumulation leading to histone H3 lysine 18 lactylation (H3K18la), which activates transcription of anti-inflammatory genes and TCA cycle genes, promoting M1-to-M2 transformation and protecting against atherosclerosis.","method":"MCT4 gene manipulation and protein hydrolysis-targeted chimerism (PROTAC), histone lactylation assays (H3K18la ChIP), gene expression profiling, atherosclerosis mouse model","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — genetic manipulation plus ChIP for lactylation mark; single lab but multiple approaches","pmids":["38733581"],"is_preprint":false},{"year":2019,"finding":"MCT4 mediates lactate-dependent stabilization and glycosylation of PD-L1 via the WNT pathway in triple-negative breast cancer cells; MCT4 knockout reduced extracellular lactate, and lactate treatment of MCT4-KO cells restored PD-L1 glycosylation.","method":"CRISPR/Cas9 MCT4 knockout, lentiviral MCT4 overexpression, exogenous lactate treatment, Western blot for PD-L1 glycosylation, multiple immunohistochemical staining","journal":"Journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2-3 — genetic KO and lactate rescue establish pathway; WNT mechanism not deeply validated; single lab","pmids":["36199799"],"is_preprint":false},{"year":2019,"finding":"MCT4 in hypothalamic tanycytes is required for metabolic signaling that regulates feeding behavior; adenoviral shRNA knockdown of MCT4 in the third ventricle decreased food intake and altered orexigenic neuropeptide responses to intracerebroventricular glucose.","method":"Adenovirus-mediated shRNA knockdown of MCT4 in rat third ventricle, food intake measurement, neuropeptide expression analysis, intracerebroventricular glucose administration","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo knockdown with defined behavioral and molecular phenotype; single lab","pmids":["31578706"],"is_preprint":false},{"year":2019,"finding":"MCT4 (and its chaperone CD147) are required for lactate export from Sertoli cells during spermatogenesis; cadmium exposure reduces MCT4 and CD147 protein levels and disrupts MCT4/CD147 co-localization at the cell membrane, thereby reducing lactate export.","method":"Co-localization fluorescence microscopy of MCT4-CD147 complex in mouse Sertoli cells, Western blot, mRNA analysis, extracellular/intracellular lactate measurement, LDH activity assay","journal":"Toxicology in vitro","confidence":"Low","confidence_rationale":"Tier 3 — co-localization without direct functional reconstitution; single lab, toxicology model","pmids":["30615929"],"is_preprint":false},{"year":2008,"finding":"PGC-1α overexpression in skeletal muscle specifically increases MCT1 (and its chaperone CD147) expression but not MCT4 or MCT2, establishing PGC-1α as a transcriptional regulator upstream of MCT1/CD147 in oxidative skeletal muscle.","method":"In vivo plasmid transfection of PGC-1α-pcDNA into rat muscle, Western blot for MCT1/MCT4/CD147, lactate uptake assay in transfected muscle, chronic stimulation model","journal":"Physiological genomics","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo transfection with functional readout; single lab but multiple muscle models","pmids":["18523157"],"is_preprint":false},{"year":2019,"finding":"NF-κB/miR-425-5p/MCT4 axis mediates diabetic endothelial injury: NF-κB activation in high-glucose conditions increases miR-425-5p, which directly targets MCT4 mRNA, reducing MCT4 expression, causing intracellular lactate accumulation and apoptosis in endothelial cells.","method":"miR-425-5p target validation (MCT4 as direct target), NF-κB activation/inhibition, miR-425-5p overexpression in HUVECs, lactate accumulation measurement, apoptosis assay","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2-3 — miRNA target validation and pathway epistasis; single lab","pmids":["31711985"],"is_preprint":false},{"year":2019,"finding":"MCT4 (not MCT4's transport activity alone) promotes actin cytoskeleton reorganization, cell migration, and invasion in glioma cells; MCT4 overexpression enhanced these processes while MCT4 inhibition mitigated angiogenesis induction.","method":"Stable MCT4 overexpression and knockdown in F98 glioma cells, migration/invasion assays, actin cytoskeleton imaging, angiogenesis assay, organotypic brain slice model, extracellular lactate/pH measurement","journal":"Journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2-3 — loss- and gain-of-function with multiple cancer hallmark readouts; single lab","pmids":["33936203"],"is_preprint":false},{"year":2019,"finding":"Global MCT4 knockout mice exhibit exercise intolerance and structural degeneration of neuromuscular junctions (NMJs) with decremented compound muscle action potentials, demonstrating that MCT4-mediated lactate export from glycolytic fibers is required for motor unit integrity.","method":"Global MCT4 knockout mice, treadmill exercise testing, compound muscle action potential recording in vivo, immunofluorescence of NMJ morphology, comparison with muscle-specific basigin conditional KO","journal":"iScience","confidence":"High","confidence_rationale":"Tier 2 — genetic KO with in vivo electrophysiology and morphological phenotype; comparison with conditional KO distinguishes MCT4-specific effects","pmids":["31837519"],"is_preprint":false},{"year":2011,"finding":"MCT4 expression in Ras-transformed tumor cells in vivo markedly increases the pH gradient between intracellular and extracellular compartments (from 0.14 to 0.43 units), and genetic loss of MCT4 combined with NHE-1 deficiency caused tumor regression, establishing MCT4 as a primary proton/lactate co-transporter driving intracellular alkalinization in tumors.","method":"In vivo MRS measurement of intracellular/extracellular pH in tumor xenografts, isogenic CCL39 variants with MCT4 and/or NHE-1 genetic deficiency, tumor growth and necrosis measurement","journal":"International journal of cancer","confidence":"High","confidence_rationale":"Tier 2 — direct in vivo pH measurement in genetically defined isogenic tumor variants; clean epistasis between MCT4 and NHE-1","pmids":["21484790"],"is_preprint":false},{"year":2010,"finding":"Wounding of RPE monolayers causes dedifferentiation with loss of MCT3 and concomitant upregulation of MCT4 in migrating cells at the wound edge; re-epithelialization restores MCT3 expression, indicating that MCT4 expression marks the dedifferentiated/migratory state of RPE cells.","method":"Scratch wounding of chick RPE/choroid explants and human fetal RPE monolayers, immunofluorescence microscopy, Western blot for MCT3 and MCT4 during wound healing and re-epithelialization","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 — direct imaging of MCT isoform switching with defined morphological context; single lab","pmids":["20505202"],"is_preprint":false}],"current_model":"SLC16A3/MCT4 is a proton-coupled lactate symporter that requires CD147/basigin as a chaperone for plasma membrane targeting and activity; it is transcriptionally induced by hypoxia via HIF-1α (and de-repressed by NF-κB-mediated silencing of the repressor FBI-1/ZBTB7A), localizes to the sarcolemma and plasma membrane of glycolytic cells to mediate high-capacity lactate and H+ efflux (with a true Km for lactate of ~1 mM), and its activity sets intracellular pH, NAD+ regeneration capacity, and extracellular lactate levels that in turn regulate immune cell function, histone lactylation, NMJ integrity, and tumor growth."},"narrative":{"teleology":[{"year":2000,"claim":"Establishing that MCT4 cannot reach the plasma membrane alone resolved the question of why heterologous MCT4 expression often failed: CD147/basigin was identified as the obligate chaperone whose transmembrane domain physically interacts with MCT4 to enable surface delivery and transport activity.","evidence":"Reciprocal co-IP, chemical cross-linking, CD2-CD147 chimera mapping, and co-transfection reconstitution in mammalian cells","pmids":["10921872"],"confidence":"High","gaps":["Stoichiometry of the MCT4–CD147 complex was not determined","Whether other auxiliary subunits participate in trafficking remains open","Structural basis of the transmembrane interaction was not resolved"]},{"year":2000,"claim":"Subcellular fractionation of skeletal muscle showed MCT4 is restricted to the sarcolemma (with an intracellular pool in triads/SR), distinguishing it from the dual sarcolemmal-mitochondrial localization of MCT1 and assigning MCT4 a dedicated plasma-membrane export role.","evidence":"Subcellular fractionation and isoform-specific Western blotting in rat skeletal muscle","pmids":["10827010"],"confidence":"Medium","gaps":["Functional significance of the triad/SR pool was not tested","No immunogold EM confirmation was provided"]},{"year":2003,"claim":"In vivo validation in basigin-null mice showed that CD147 is required post-transcriptionally for MCT4 protein stability, not just trafficking—MCT4 protein was severely depleted despite normal mRNA, extending the chaperone model from cell lines to intact tissue.","evidence":"Bsg−/− knockout mice with immunofluorescence, Western blot, and RT-PCR in neural retina","pmids":["12601063"],"confidence":"High","gaps":["Whether CD147 loss leads to proteasomal or lysosomal degradation of MCT4 was not determined","Rescue by CD147 re-expression was not performed"]},{"year":2006,"claim":"Identification of a functional HRE in the SLC16A3 promoter directly bound by HIF-1α established the molecular basis for hypoxia-induced MCT4 upregulation, explaining why MCT4 is the predominant lactate transporter in hypoxic and glycolytic tissues.","evidence":"Promoter-luciferase reporters, HRE deletion/point mutation, gel-shift and supershift assays in hypoxic HeLa cells","pmids":["16452478"],"confidence":"High","gaps":["Contribution of HIF-2α was not addressed","Chromatin context (histone modifications at the HRE) was not examined"]},{"year":2011,"claim":"Functional studies in tumors demonstrated that MCT4 is a primary driver of intracellular alkalinization and lactate efflux required for tumor growth: MCT4 knockout reduced glycolytic flux, collapsed the pH gradient, and—combined with NHE-1 loss—caused tumor regression, while MCT4 re-expression rescued tumorigenicity in respiration-deficient cells.","evidence":"ZFN-mediated MCT4 KO in colon adenocarcinoma, in vivo MRS pH measurement in isogenic tumor variants, xenograft growth assays","pmids":["21930917","21484790"],"confidence":"High","gaps":["Whether MCT4 loss selects for compensatory transporter upregulation in vivo was not examined","Immune microenvironment effects were not assessed in these xenograft (immunodeficient host) models"]},{"year":2013,"claim":"Genome-wide RNAi screening in renal clear cell carcinoma independently confirmed MCT4 as essential for the Warburg effect, showing that MCT4 silencing causes intracellular acidosis, ATP depletion, cell-cycle arrest, and apoptosis, while promoter DNA methylation was identified as an epigenetic regulator of SLC16A3 expression.","evidence":"Genome-wide RNAi screen, siRNA across 8 ccRCC lines, intracellular pH/ATP/lactate assays; bisulfite sequencing and promoter-luciferase assays","pmids":["22362593","23881922"],"confidence":"High","gaps":["The methyltransferase(s) responsible for SLC16A3 promoter methylation were not identified","Whether demethylation agents restore MCT4 and sensitize tumors was not tested in vivo"]},{"year":2015,"claim":"Mutagenesis of His382 in the extracellular loop revealed the molecular basis for pH-dependent regulation of MCT4 transport, answering how extracellular acidification modulates lactate efflux kinetics.","evidence":"Site-directed mutagenesis (H382A), DEPC chemical modification, Zn²⁺ inhibition, Xenopus oocyte expression and uptake assays at varied pH","pmids":["25919709"],"confidence":"High","gaps":["No crystal or cryo-EM structure was available to place His382 in a three-dimensional context","Whether His382 regulation is conserved across MCT family members was not tested"]},{"year":2018,"claim":"Pharmacological dual MCT1/MCT4 inhibition with syrosingopine revealed that blocking MCT4-dependent lactate export causes intracellular lactate accumulation sufficient to inhibit LDH and collapse NAD⁺ regeneration, establishing a metabolic vulnerability that is synthetically lethal with metformin.","evidence":"Syrosingopine treatment of cancer cells, intracellular lactate and NAD⁺/NADH measurements, exogenous NAD⁺ rescue, metformin combination lethality","pmids":["30540938"],"confidence":"High","gaps":["Direct binding site of syrosingopine on MCT4 was not mapped","In vivo pharmacokinetics and toxicity of syrosingopine–metformin combination were not established"]},{"year":2019,"claim":"Revised kinetic analysis using intracellular FRET sensors corrected the MCT4 Km for lactate from ~30 mM to ~1 mM, fundamentally changing the understanding of MCT4 as a high-affinity rather than low-affinity transporter and explaining its efficacy even at modest intracellular lactate concentrations.","evidence":"FRET sensors (Laconic, Pyronic), CRISPR/Cas9 MCT4 deletion in MDA-MB-231 cells and macrophages, numerical simulation","pmids":["31719150"],"confidence":"High","gaps":["Km under physiological intracellular ionic conditions and with native CD147 stoichiometry remains to be confirmed in intact tissue","Pyruvate transport kinetics were less thoroughly validated"]},{"year":2019,"claim":"A second layer of transcriptional control was uncovered: NF-κB represses ZBTB7A/FBI-1, which normally occupies the SLC16A3 promoter at both FBI-1 response elements and HREs, so that hypoxia simultaneously activates HIF-1α and removes FBI-1 repression, providing a dual-input logic gate for MCT4 induction.","evidence":"ChIP, oligonucleotide pulldown, promoter-luciferase reporters, siRNA knockdown of ZBTB7A and HIF-1α in colon cancer cells","pmids":["31271899"],"confidence":"Medium","gaps":["Whether FBI-1 physically competes with HIF-1α for HRE occupancy or acts at distinct elements was not fully resolved","Single-lab finding; independent replication needed"]},{"year":2019,"claim":"Global MCT4 knockout mice exhibited exercise intolerance and structural NMJ degeneration with decremented compound muscle action potentials, demonstrating that MCT4-mediated lactate export from glycolytic muscle fibers is essential for neuromuscular junction integrity in vivo.","evidence":"MCT4 global knockout mice, treadmill testing, in vivo electrophysiology, NMJ immunofluorescence, comparison with muscle-specific basigin conditional KO","pmids":["31837519"],"confidence":"High","gaps":["Whether the NMJ defect is due to lactate/pH imbalance in the muscle fiber or loss of lactate signaling to Schwann cells/motor neurons was not distinguished","Rescue by MCT4 re-expression in specific cell types was not performed"]},{"year":2023,"claim":"MCT4-mediated tumor lactate export was shown to create an immunosuppressive microenvironment: MCT4 knockout reversed M2 macrophage polarization, restored T-cell function, and sensitized LKB1-mutant tumors to anti-PD-1 therapy, connecting metabolic transport directly to immune evasion.","evidence":"MCT4 KO in syngeneic murine tumor models, PD-1 blockade, single-cell RNA profiling, GPR81 blockade epistasis, exogenous lactate rescue","pmids":["37327788"],"confidence":"High","gaps":["Whether MCT4 inhibition benefits immunotherapy in non-LKB1-mutant contexts was not tested","Selective MCT4 inhibitors suitable for clinical translation were not available"]},{"year":2024,"claim":"MCT4 deficiency in macrophages was found to drive intracellular lactate accumulation that promotes histone H3K18 lactylation, activating anti-inflammatory and TCA cycle gene programs—revealing a cell-intrinsic epigenetic mechanism by which MCT4 loss reprograms macrophage identity toward an M2-like state.","evidence":"MCT4 gene manipulation and PROTAC degradation in macrophages, H3K18la ChIP, gene expression profiling, atherosclerosis mouse model","pmids":["38733581"],"confidence":"Medium","gaps":["Whether lactylation-driven reprogramming occurs in other immune cell types was not tested","The writer enzyme for H3K18la in this context was not identified","Single-lab finding"]},{"year":null,"claim":"No high-resolution structure of MCT4 (alone or in complex with CD147) has been determined, and no selective, clinically viable MCT4 inhibitor exists; the structural basis of substrate selectivity, the mechanism by which CD147 stabilizes MCT4, and whether MCT4 has non-transport (scaffolding) functions remain open.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure of MCT4 or MCT4–CD147 complex","No selective MCT4 inhibitor with demonstrated in vivo efficacy and safety","Whether MCT4 has transport-independent signaling or scaffolding functions is unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[2,5,6,11,13,24]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[1,3,4,23]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[2,5,6,13,24]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[2,5,11,13]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,6,15,24]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[15,16]}],"complexes":["MCT4–CD147/basigin complex"],"partners":["BSG","HIF1A","ZBTB7A","SLC9A1"],"other_free_text":[]},"mechanistic_narrative":"SLC16A3 encodes MCT4, a proton-coupled monocarboxylate transporter that mediates high-capacity efflux of lactate and H⁺ from glycolytic cells, thereby maintaining intracellular pH homeostasis, sustaining NAD⁺ regeneration, and shaping the extracellular metabolic milieu. MCT4 requires the chaperone CD147/basigin for post-transcriptional stabilization and trafficking to the plasma membrane; without CD147, MCT4 protein is severely reduced despite normal mRNA levels [PMID:10921872, PMID:12601063]. Transcription of SLC16A3 is directly activated by HIF-1α via a hypoxia-response element in its promoter and further de-repressed under hypoxia through NF-κB–mediated downregulation of the transcriptional repressor ZBTB7A/FBI-1, while promoter DNA methylation provides an additional layer of epigenetic silencing [PMID:16452478, PMID:31271899, PMID:23881922]. Loss of MCT4 causes intracellular lactate accumulation that inhibits glycolysis, triggers histone lactylation-dependent transcriptional reprogramming in macrophages, impairs neuromuscular junction integrity in vivo, and—in tumors—restricts growth and restores sensitivity to immune checkpoint blockade [PMID:30540938, PMID:38733581, PMID:31837519, PMID:37327788]."},"prefetch_data":{"uniprot":{"accession":"O15427","full_name":"Monocarboxylate transporter 4","aliases":["Solute carrier family 16 member 3"],"length_aa":465,"mass_kda":49.5,"function":"Proton-dependent transporter of monocarboxylates such as L-lactate and pyruvate (PubMed:11101640, PubMed:23935841, PubMed:31719150). Plays a predominant role in L-lactate efflux from highly glycolytic cells (By similarity)","subcellular_location":"Cell membrane; Basolateral cell membrane","url":"https://www.uniprot.org/uniprotkb/O15427/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC16A3","classification":"Not Classified","n_dependent_lines":36,"n_total_lines":1208,"dependency_fraction":0.029801324503311258},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC16A3","total_profiled":1310},"omim":[{"mim_id":"603880","title":"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 6; SLC16A6","url":"https://www.omim.org/entry/603880"},{"mim_id":"603879","title":"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 5; SLC16A5","url":"https://www.omim.org/entry/603879"},{"mim_id":"603878","title":"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 4; SLC16A4","url":"https://www.omim.org/entry/603878"},{"mim_id":"603877","title":"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 3; SLC16A3","url":"https://www.omim.org/entry/603877"},{"mim_id":"600682","title":"SOLUTE CARRIER FAMILY 16 (MONOCARBOXYLIC ACID TRANSPORTER), MEMBER 1; SLC16A1","url":"https://www.omim.org/entry/600682"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nuclear membrane","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"skeletal muscle","ntpm":134.4}],"url":"https://www.proteinatlas.org/search/SLC16A3"},"hgnc":{"alias_symbol":["MCT3","MCT4"],"prev_symbol":[]},"alphafold":{"accession":"O15427","domains":[{"cath_id":"1.20.1250.20","chopping":"16-200","consensus_level":"medium","plddt":94.0817,"start":16,"end":200},{"cath_id":"1.20.1250.20","chopping":"219-412","consensus_level":"medium","plddt":92.2231,"start":219,"end":412}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O15427","model_url":"https://alphafold.ebi.ac.uk/files/AF-O15427-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O15427-F1-predicted_aligned_error_v6.png","plddt_mean":83.62},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC16A3","jax_strain_url":"https://www.jax.org/strain/search?query=SLC16A3"},"sequence":{"accession":"O15427","fasta_url":"https://rest.uniprot.org/uniprotkb/O15427.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O15427/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O15427"}},"corpus_meta":[{"pmid":"16452478","id":"PMC_16452478","title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16452478","citation_count":748,"is_preprint":false},{"pmid":"10921872","id":"PMC_10921872","title":"CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.","date":"2000","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10921872","citation_count":569,"is_preprint":false},{"pmid":"21930917","id":"PMC_21930917","title":"CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21930917","citation_count":364,"is_preprint":false},{"pmid":"21558814","id":"PMC_21558814","title":"Evidence for a stromal-epithelial \"lactate shuttle\" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.","date":"2011","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/21558814","citation_count":353,"is_preprint":false},{"pmid":"30540938","id":"PMC_30540938","title":"Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30540938","citation_count":307,"is_preprint":false},{"pmid":"10751188","id":"PMC_10751188","title":"Endurance training, expression, and physiology of LDH, MCT1, and MCT4 in human skeletal muscle.","date":"2000","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10751188","citation_count":265,"is_preprint":false},{"pmid":"9632638","id":"PMC_9632638","title":"Lactic acid efflux from white skeletal muscle is catalyzed by the monocarboxylate transporter isoform MCT3.","date":"1998","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9632638","citation_count":231,"is_preprint":false},{"pmid":"11820324","id":"PMC_11820324","title":"The expression of lactate transporters (MCT1 and MCT4) in heart and muscle.","date":"2001","source":"European journal of applied physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11820324","citation_count":217,"is_preprint":false},{"pmid":"12601063","id":"PMC_12601063","title":"Loss of MCT1, MCT3, and MCT4 expression in the retinal pigment epithelium and neural retina of the 5A11/basigin-null mouse.","date":"2003","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/12601063","citation_count":197,"is_preprint":false},{"pmid":"23574725","id":"PMC_23574725","title":"Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23574725","citation_count":197,"is_preprint":false},{"pmid":"26876179","id":"PMC_26876179","title":"MCT1 Modulates Cancer Cell Pyruvate Export and Growth of Tumors that Co-express MCT1 and MCT4.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26876179","citation_count":191,"is_preprint":false},{"pmid":"14622911","id":"PMC_14622911","title":"Highly differential expression of the monocarboxylate transporters MCT2 and MCT4 in the developing rat brain.","date":"2003","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/14622911","citation_count":181,"is_preprint":false},{"pmid":"21569415","id":"PMC_21569415","title":"Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.","date":"2011","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21569415","citation_count":178,"is_preprint":false},{"pmid":"31719150","id":"PMC_31719150","title":"Monocarboxylate transporter 4 (MCT4) is a high affinity transporter capable of exporting lactate in high-lactate microenvironments.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31719150","citation_count":159,"is_preprint":false},{"pmid":"9841555","id":"PMC_9841555","title":"Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE.","date":"1998","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/9841555","citation_count":135,"is_preprint":false},{"pmid":"37327788","id":"PMC_37327788","title":"MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma.","date":"2023","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/37327788","citation_count":133,"is_preprint":false},{"pmid":"9168967","id":"PMC_9168967","title":"Identification of a unique monocarboxylate transporter (MCT3) in retinal pigment epithelium.","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9168967","citation_count":108,"is_preprint":false},{"pmid":"11287345","id":"PMC_11287345","title":"Mouse MCT3 gene is expressed preferentially in retinal pigment and choroid plexus epithelia.","date":"2001","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/11287345","citation_count":101,"is_preprint":false},{"pmid":"25058459","id":"PMC_25058459","title":"Expression of the hypoxia-inducible monocarboxylate transporter MCT4 is increased in triple negative breast cancer and correlates independently with clinical outcome.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25058459","citation_count":95,"is_preprint":false},{"pmid":"30416849","id":"PMC_30416849","title":"An overview of MCT1 and MCT4 in GBM: small molecule transporters with large implications.","date":"2018","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30416849","citation_count":94,"is_preprint":false},{"pmid":"11052969","id":"PMC_11052969","title":"Isoform-specific regulation of the lactate transporters MCT1 and MCT4 by contractile activity.","date":"2000","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11052969","citation_count":94,"is_preprint":false},{"pmid":"21484790","id":"PMC_21484790","title":"In vivo pH in metabolic-defective Ras-transformed fibroblast tumors: key role of the monocarboxylate transporter, MCT4, for inducing an alkaline intracellular pH.","date":"2011","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/21484790","citation_count":93,"is_preprint":false},{"pmid":"22362593","id":"PMC_22362593","title":"Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target.","date":"2012","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/22362593","citation_count":91,"is_preprint":false},{"pmid":"24610532","id":"PMC_24610532","title":"Acute exercise increases brain region-specific expression of MCT1, MCT2, MCT4, GLUT1, and COX IV proteins.","date":"2014","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/24610532","citation_count":91,"is_preprint":false},{"pmid":"23881922","id":"PMC_23881922","title":"DNA methylation of the SLC16A3 promoter regulates expression of the human lactate transporter MCT4 in renal cancer with consequences for clinical outcome.","date":"2013","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/23881922","citation_count":88,"is_preprint":false},{"pmid":"22012699","id":"PMC_22012699","title":"Effects of acute and chronic exercise on sarcolemmal MCT1 and MCT4 contents in human skeletal muscles: current status.","date":"2011","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22012699","citation_count":87,"is_preprint":false},{"pmid":"10827010","id":"PMC_10827010","title":"Abundance and subcellular distribution of MCT1 and MCT4 in heart and fast-twitch skeletal muscles.","date":"2000","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10827010","citation_count":86,"is_preprint":false},{"pmid":"26755530","id":"PMC_26755530","title":"The MCT4 Gene: A Novel, Potential Target for Therapy of Advanced Prostate Cancer.","date":"2016","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/26755530","citation_count":83,"is_preprint":false},{"pmid":"37880183","id":"PMC_37880183","title":"MCT4 blockade increases the efficacy of immune checkpoint blockade.","date":"2023","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/37880183","citation_count":81,"is_preprint":false},{"pmid":"15932892","id":"PMC_15932892","title":"Immunohistochemical analysis of MCT1, MCT2 and MCT4 expression in rat plantaris muscle.","date":"2005","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15932892","citation_count":80,"is_preprint":false},{"pmid":"31418947","id":"PMC_31418947","title":"Inhibition of CREB-mediated ZO-1 and activation of NF-κB-induced IL-6 by colonic epithelial MCT4 destroys intestinal barrier function.","date":"2019","source":"Cell proliferation","url":"https://pubmed.ncbi.nlm.nih.gov/31418947","citation_count":80,"is_preprint":false},{"pmid":"38733581","id":"PMC_38733581","title":"Macrophage MCT4 inhibition activates reparative genes and protects from atherosclerosis by histone H3 lysine 18 lactylation.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/38733581","citation_count":77,"is_preprint":false},{"pmid":"26765963","id":"PMC_26765963","title":"Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.","date":"2016","source":"Pancreas","url":"https://pubmed.ncbi.nlm.nih.gov/26765963","citation_count":77,"is_preprint":false},{"pmid":"25965974","id":"PMC_25965974","title":"Functional screening identifies MCT4 as a key regulator of breast cancer cell metabolism and survival.","date":"2015","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25965974","citation_count":77,"is_preprint":false},{"pmid":"16959859","id":"PMC_16959859","title":"Testosterone increases lactate transport, monocarboxylate transporter (MCT) 1 and MCT4 in rat skeletal muscle.","date":"2006","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/16959859","citation_count":76,"is_preprint":false},{"pmid":"29026134","id":"PMC_29026134","title":"MCT1 and MCT4 Expression and Lactate Flux Activity Increase During White and Brown Adipogenesis and Impact Adipocyte Metabolism.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29026134","citation_count":76,"is_preprint":false},{"pmid":"18523157","id":"PMC_18523157","title":"PGC-1alpha increases skeletal muscle lactate uptake by increasing the expression of MCT1 but not MCT2 or MCT4.","date":"2008","source":"Physiological genomics","url":"https://pubmed.ncbi.nlm.nih.gov/18523157","citation_count":74,"is_preprint":false},{"pmid":"23860378","id":"PMC_23860378","title":"Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment: RAS and NFκB target stromal MCT4.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23860378","citation_count":72,"is_preprint":false},{"pmid":"24375723","id":"PMC_24375723","title":"Oxygen tension controls the expression of the monocarboxylate transporter MCT4 in cultured mouse cortical astrocytes via a hypoxia-inducible factor-1α-mediated transcriptional regulation.","date":"2013","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/24375723","citation_count":71,"is_preprint":false},{"pmid":"16116050","id":"PMC_16116050","title":"Inactivation of monocarboxylate transporter MCT3 by DNA methylation in atherosclerosis.","date":"2005","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/16116050","citation_count":65,"is_preprint":false},{"pmid":"29363134","id":"PMC_29363134","title":"The net acid extruders NHE1, NBCn1 and MCT4 promote mammary tumor growth through distinct but overlapping mechanisms.","date":"2018","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29363134","citation_count":64,"is_preprint":false},{"pmid":"30262589","id":"PMC_30262589","title":"Selective Inhibition of the Lactate Transporter MCT4 Reduces Growth of Invasive Bladder Cancer.","date":"2018","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/30262589","citation_count":63,"is_preprint":false},{"pmid":"10924129","id":"PMC_10924129","title":"Determination of transport kinetics of chick MCT3 monocarboxylate transporter from retinal pigment epithelium by expression in genetically modified yeast.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10924129","citation_count":62,"is_preprint":false},{"pmid":"15388779","id":"PMC_15388779","title":"Exercise rapidly increases expression of the monocarboxylate transporters MCT1 and MCT4 in rat muscle.","date":"2004","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15388779","citation_count":62,"is_preprint":false},{"pmid":"22350013","id":"PMC_22350013","title":"Butyrate activates the monocarboxylate transporter MCT4 expression in breast cancer cells and enhances the antitumor activity of 3-bromopyruvate.","date":"2012","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/22350013","citation_count":59,"is_preprint":false},{"pmid":"29905005","id":"PMC_29905005","title":"Targeting MCT4 to reduce lactic acid secretion and glycolysis for treatment of neuroendocrine prostate cancer.","date":"2018","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29905005","citation_count":57,"is_preprint":false},{"pmid":"17289302","id":"PMC_17289302","title":"Expression, cellular localization, and functional role of monocarboxylate transporter 4 (MCT4) in the gastrointestinal tract of ruminants.","date":"2007","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/17289302","citation_count":53,"is_preprint":false},{"pmid":"17609257","id":"PMC_17609257","title":"Effects of high-intensity training on MCT1, MCT4, and NBC expressions in rat skeletal muscles: influence of chronic metabolic alkalosis.","date":"2007","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/17609257","citation_count":50,"is_preprint":false},{"pmid":"30051648","id":"PMC_30051648","title":"Downregulation of MCT4 for lactate exchange promotes the cytotoxicity of NK cells in breast carcinoma.","date":"2018","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30051648","citation_count":48,"is_preprint":false},{"pmid":"35561786","id":"PMC_35561786","title":"TGF-β1 induced autophagy in cancer associated fibroblasts during hypoxia contributes EMT and glycolysis via MCT4 upregulation.","date":"2022","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/35561786","citation_count":47,"is_preprint":false},{"pmid":"33614502","id":"PMC_33614502","title":"Targeting Lactate Metabolism by Inhibiting MCT1 or MCT4 Impairs Leukemic Cell Proliferation, Induces Two Different Related Death-Pathways and Increases Chemotherapeutic Sensitivity of Acute Myeloid Leukemia Cells.","date":"2021","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33614502","citation_count":46,"is_preprint":false},{"pmid":"29483215","id":"PMC_29483215","title":"MCT4 Expression Is a Potential Therapeutic Target in Colorectal Cancer with Peritoneal Carcinomatosis.","date":"2018","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/29483215","citation_count":44,"is_preprint":false},{"pmid":"24030048","id":"PMC_24030048","title":"MCT1 and MCT4 expression during myocardial ischemic-reperfusion injury in the isolated rat heart.","date":"2013","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24030048","citation_count":43,"is_preprint":false},{"pmid":"38522774","id":"PMC_38522774","title":"Targeting tumor-intrinsic SLC16A3 to enhance anti-PD-1 efficacy via tumor immune microenvironment reprogramming.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38522774","citation_count":41,"is_preprint":false},{"pmid":"27236641","id":"PMC_27236641","title":"Effect of diclofenac on SLC16A3/MCT4 by the Caco-2 cell line.","date":"2016","source":"Drug metabolism and pharmacokinetics","url":"https://pubmed.ncbi.nlm.nih.gov/27236641","citation_count":41,"is_preprint":false},{"pmid":"30211114","id":"PMC_30211114","title":"Monocarboxylate Transporter 4 (MCT4) Knockout Mice Have Attenuated 4NQO Induced Carcinogenesis; A Role for MCT4 in Driving Oral Squamous Cell Cancer.","date":"2018","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30211114","citation_count":40,"is_preprint":false},{"pmid":"26854723","id":"PMC_26854723","title":"Butyric acid increases transepithelial transport of ferulic acid through upregulation of the monocarboxylate transporters SLC16A1 (MCT1) and SLC16A3 (MCT4).","date":"2016","source":"Archives of biochemistry and biophysics","url":"https://pubmed.ncbi.nlm.nih.gov/26854723","citation_count":38,"is_preprint":false},{"pmid":"23780984","id":"PMC_23780984","title":"Expression of monocarboxylate transporter (MCT)-4 in colorectal cancer and its role: MCT4 contributes to the growth of colorectal cancer with vascular endothelial growth factor.","date":"2013","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/23780984","citation_count":38,"is_preprint":false},{"pmid":"31271899","id":"PMC_31271899","title":"Hypoxia-induced RelA/p65 derepresses SLC16A3 (MCT4) by downregulating ZBTB7A.","date":"2019","source":"Biochimica et biophysica acta. Gene regulatory mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/31271899","citation_count":36,"is_preprint":false},{"pmid":"23907124","id":"PMC_23907124","title":"Loss of caveolin-1 and gain of MCT4 expression in the tumor stroma: key events in the progression from an in situ to an invasive breast carcinoma.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23907124","citation_count":36,"is_preprint":false},{"pmid":"34517305","id":"PMC_34517305","title":"Novel strategies to improve tumour therapy by targeting the proteins MCT1, MCT4 and LAT1.","date":"2021","source":"European journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34517305","citation_count":35,"is_preprint":false},{"pmid":"24081524","id":"PMC_24081524","title":"Effect of AMPK activation on monocarboxylate transporter (MCT)1 and MCT4 in denervated muscle.","date":"2013","source":"The journal of physiological sciences : JPS","url":"https://pubmed.ncbi.nlm.nih.gov/24081524","citation_count":32,"is_preprint":false},{"pmid":"11551851","id":"PMC_11551851","title":"Tissue-specific and isoform-specific changes in MCT1 and MCT4 in heart and soleus muscle during a 1-yr period.","date":"2001","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/11551851","citation_count":31,"is_preprint":false},{"pmid":"34097251","id":"PMC_34097251","title":"The tissue expression of MCT3, MCT8, and MCT9 genes in women with breast cancer.","date":"2021","source":"Genes & genomics","url":"https://pubmed.ncbi.nlm.nih.gov/34097251","citation_count":30,"is_preprint":false},{"pmid":"20505202","id":"PMC_20505202","title":"Modulation of MCT3 expression during wound healing of the retinal pigment epithelium.","date":"2010","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/20505202","citation_count":30,"is_preprint":false},{"pmid":"21148623","id":"PMC_21148623","title":"Effect of training and detraining on monocarboxylate transporter (MCT) 1 and MCT4 in Thoroughbred horses.","date":"2010","source":"Experimental physiology","url":"https://pubmed.ncbi.nlm.nih.gov/21148623","citation_count":29,"is_preprint":false},{"pmid":"16901736","id":"PMC_16901736","title":"Expression of CD147 and monocarboxylate transporters MCT1, MCT2 and MCT4 in porcine small intestine and colon.","date":"2006","source":"Veterinary journal (London, England : 1997)","url":"https://pubmed.ncbi.nlm.nih.gov/16901736","citation_count":29,"is_preprint":false},{"pmid":"15953554","id":"PMC_15953554","title":"Expression of MCT1, MCT2 and MCT4 in the rumen, small intestine and liver of reindeer (Rangifer tarandus tarandus L.).","date":"2005","source":"Comparative biochemistry and physiology. Part A, Molecular & integrative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15953554","citation_count":29,"is_preprint":false},{"pmid":"31711985","id":"PMC_31711985","title":"The NF-κB/miR-425-5p/MCT4 axis: A novel insight into diabetes-induced endothelial dysfunction.","date":"2019","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31711985","citation_count":28,"is_preprint":false},{"pmid":"32686211","id":"PMC_32686211","title":"Disrupted function of lactate transporter MCT1, but not MCT4, in Schwann cells affects the maintenance of motor end-plate innervation.","date":"2020","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/32686211","citation_count":28,"is_preprint":false},{"pmid":"12900382","id":"PMC_12900382","title":"T3 increases lactate transport and the expression of MCT4, but not MCT1, in rat skeletal muscle.","date":"2003","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/12900382","citation_count":27,"is_preprint":false},{"pmid":"23886299","id":"PMC_23886299","title":"Possible involvement of AMPK in acute exercise-induced expression of monocarboxylate transporters MCT1 and MCT4 mRNA in fast-twitch skeletal muscle.","date":"2013","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/23886299","citation_count":27,"is_preprint":false},{"pmid":"35509603","id":"PMC_35509603","title":"Lactate Transporter SLC16A3 (MCT4) as an Onco-Immunological Biomarker Associating Tumor Microenvironment and Immune Responses in Lung Cancer.","date":"2022","source":"International journal of general medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35509603","citation_count":26,"is_preprint":false},{"pmid":"34077729","id":"PMC_34077729","title":"Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition.","date":"2021","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/34077729","citation_count":26,"is_preprint":false},{"pmid":"36610137","id":"PMC_36610137","title":"Formosanin C inhibits non-small-cell lung cancer progression by blocking MCT4/CD147-mediated lactate export.","date":"2022","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36610137","citation_count":25,"is_preprint":false},{"pmid":"36658582","id":"PMC_36658582","title":"Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis.","date":"2023","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/36658582","citation_count":25,"is_preprint":false},{"pmid":"31837519","id":"PMC_31837519","title":"New Insights into the Lactate Shuttle: Role of MCT4 in the Modulation of the Exercise Capacity.","date":"2019","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/31837519","citation_count":25,"is_preprint":false},{"pmid":"12492781","id":"PMC_12492781","title":"Distribution of monocarboxylate transporter isoforms MCT1, MCT2 and MCT4 in porcine muscles.","date":"2003","source":"Acta physiologica Scandinavica","url":"https://pubmed.ncbi.nlm.nih.gov/12492781","citation_count":24,"is_preprint":false},{"pmid":"18385447","id":"PMC_18385447","title":"Characterization and regulation of monocarboxylate cotransporters Slc16a7 and Slc16a3 in preimplantation mouse embryos.","date":"2008","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/18385447","citation_count":23,"is_preprint":false},{"pmid":"21901758","id":"PMC_21901758","title":"Nitric oxide induces the expression of the monocarboxylate transporter MCT4 in cultured astrocytes by a cGMP-independent transcriptional activation.","date":"2011","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/21901758","citation_count":22,"is_preprint":false},{"pmid":"36199799","id":"PMC_36199799","title":"MCT4/Lactate Promotes PD-L1 Glycosylation in Triple-Negative Breast Cancer Cells.","date":"2022","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36199799","citation_count":22,"is_preprint":false},{"pmid":"31661586","id":"PMC_31661586","title":"A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma.","date":"2019","source":"Veterinary and comparative oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31661586","citation_count":21,"is_preprint":false},{"pmid":"30615929","id":"PMC_30615929","title":"Exposure to Pb and Cd alters MCT4/CD147 expression and MCT4/CD147-dependent lactate transport in mice Sertoli cells cultured in vitro.","date":"2019","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/30615929","citation_count":20,"is_preprint":false},{"pmid":"26202642","id":"PMC_26202642","title":"Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia.","date":"2014","source":"Hepatology international","url":"https://pubmed.ncbi.nlm.nih.gov/26202642","citation_count":19,"is_preprint":false},{"pmid":"25919709","id":"PMC_25919709","title":"Involvement of Histidine Residue His382 in pH Regulation of MCT4 Activity.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25919709","citation_count":18,"is_preprint":false},{"pmid":"31217781","id":"PMC_31217781","title":"MCT4 promotes cell proliferation and invasion of castration-resistant prostate cancer PC-3 cell line.","date":"2019","source":"EXCLI journal","url":"https://pubmed.ncbi.nlm.nih.gov/31217781","citation_count":18,"is_preprint":false},{"pmid":"36814318","id":"PMC_36814318","title":"Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis.","date":"2023","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/36814318","citation_count":17,"is_preprint":false},{"pmid":"31578706","id":"PMC_31578706","title":"Inhibition of Hypothalamic MCT4 and MCT1-MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions.","date":"2019","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/31578706","citation_count":17,"is_preprint":false},{"pmid":"33936203","id":"PMC_33936203","title":"MCT4 Promotes Tumor Malignancy in F98 Glioma Cells.","date":"2021","source":"Journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33936203","citation_count":17,"is_preprint":false},{"pmid":"23187830","id":"PMC_23187830","title":"Expression and role of GLUT-1, MCT-1, and MCT-4 in malignant pleural mesothelioma.","date":"2012","source":"Virchows Archiv : an international journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23187830","citation_count":16,"is_preprint":false},{"pmid":"38240467","id":"PMC_38240467","title":"Exercise influence on monocarboxylate transporter 1 (MCT1) and 4 (MCT4) in the skeletal muscle: A systematic review.","date":"2024","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/38240467","citation_count":16,"is_preprint":false},{"pmid":"25470525","id":"PMC_25470525","title":"MCT1 and MCT4 kinetic of mRNA expression in different tissues after aerobic exercise at maximal lactate steady state workload.","date":"2014","source":"Physiological research","url":"https://pubmed.ncbi.nlm.nih.gov/25470525","citation_count":15,"is_preprint":false},{"pmid":"35615882","id":"PMC_35615882","title":"GLUT1, LDHA, and MCT4 Expression Is Deregulated in Cervical Cancer and Precursor Lesions.","date":"2022","source":"The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society","url":"https://pubmed.ncbi.nlm.nih.gov/35615882","citation_count":15,"is_preprint":false},{"pmid":"16110503","id":"PMC_16110503","title":"MCT-4, A511/Basigin and EF5 expression patterns during early chick cardiomyogenesis indicate cardiac cell differentiation occurs in a hypoxic environment.","date":"2006","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/16110503","citation_count":15,"is_preprint":false},{"pmid":"23843845","id":"PMC_23843845","title":"The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma.","date":"2013","source":"Journal of breast cancer","url":"https://pubmed.ncbi.nlm.nih.gov/23843845","citation_count":14,"is_preprint":false},{"pmid":"34172808","id":"PMC_34172808","title":"MCT4 is induced by metastasis-enhancing pathogenic mitochondrial NADH dehydrogenase gene mutations and can be a therapeutic target.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34172808","citation_count":14,"is_preprint":false},{"pmid":"21826525","id":"PMC_21826525","title":"Expression of monocarboxylate transporter (MCT) 1 and MCT4 in overloaded mice plantaris muscle.","date":"2011","source":"The journal of physiological sciences : JPS","url":"https://pubmed.ncbi.nlm.nih.gov/21826525","citation_count":14,"is_preprint":false},{"pmid":"18056982","id":"PMC_18056982","title":"Rapid upregulation of GLUT-4 and MCT-4 expression during 16 h of heavy intermittent cycle exercise.","date":"2007","source":"American journal of physiology. Regulatory, integrative and comparative physiology","url":"https://pubmed.ncbi.nlm.nih.gov/18056982","citation_count":14,"is_preprint":false},{"pmid":"36104287","id":"PMC_36104287","title":"Involvement of SLC16A1/MCT1 and SLC16A3/MCT4 in l-lactate transport in the hepatocellular carcinoma cell line.","date":"2022","source":"Biopharmaceutics & drug disposition","url":"https://pubmed.ncbi.nlm.nih.gov/36104287","citation_count":13,"is_preprint":false},{"pmid":"9820789","id":"PMC_9820789","title":"Genomic structure and developmental expression of the chicken nonocarboxylate transporter MCT3 gene.","date":"1998","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/9820789","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":53358,"output_tokens":6308,"usd":0.127347},"stage2":{"model":"claude-opus-4-6","input_tokens":10010,"output_tokens":3755,"usd":0.215888},"total_usd":0.343235,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"MCT4 (SLC16A3) expression is transcriptionally upregulated by hypoxia through HIF-1α binding to hypoxia-response elements in the MCT4 promoter; mutation of a specific HRE (site 2) abolished the hypoxic response, and gel-shift/supershift assays confirmed direct HIF-1α binding.\",\n      \"method\": \"Promoter-luciferase reporter assays, deletion and mutation analysis, gel-shift and supershift analysis with nuclear extracts from hypoxic HeLa cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods (reporter assay, deletion mapping, mutagenesis, EMSA supershift) in a single rigorous study\",\n      \"pmids\": [\"16452478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"CD147 specifically interacts with MCT4 (and MCT1) via its transmembrane and cytoplasmic domains, and this interaction is required for proper cell-surface expression of MCT4; co-transfection of CD147 with MCT4 enabled plasma membrane localization and transport activity, whereas MCT4 alone accumulated in a perinuclear compartment.\",\n      \"method\": \"Co-immunoprecipitation, chemical cross-linking, CD2-CD147 chimera studies, co-transfection in mammalian cell lines, immunofluorescence co-localization, functional transport assay\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reciprocal co-IP, cross-linking, chimera mapping, reconstitution of transport activity; replicated across multiple labs\",\n      \"pmids\": [\"10921872\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MCT4 is a high-affinity lactate transporter with Km ~0.7–1.7 mM for lactate (not ~30–40 mM as previously reported), and also transports pyruvate with Km ~4.2 mM. Previous high Km estimates were biased by pH-regulatory mechanisms. CRISPR/Cas9 deletion confirmed MCT4 as the dominant lactate transporter in MDA-MB-231 cells and macrophages.\",\n      \"method\": \"FRET sensors (Laconic, Pyronic) for real-time lactate/pyruvate dynamics, CRISPR/Cas9-mediated MCT4 deletion, pH-sensitive dye (BCECF), recombinant MCT4 expression in HEK293 cells, numerical simulation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including genetic knockout and recombinant reconstitution with rigorous kinetic analysis\",\n      \"pmids\": [\"31719150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MCT4 localizes exclusively to the sarcolemmal membrane in skeletal muscle (not mitochondria), whereas MCT1 is found in both sarcolemmal and mitochondrial membranes, indicating distinct subcellular roles; MCT4 also has a significant intracellular pool in triads and sarcoplasmic reticulum.\",\n      \"method\": \"Subcellular fractionation (plasma membrane, triads, T-tubules, sarcoplasmic reticulum, intracellular membrane fractions), Western blotting with isoform-specific antibodies\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct fractionation with isoform-specific antibodies; single lab\",\n      \"pmids\": [\"10827010\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In basigin (CD147)-null mice, MCT4 protein is severely reduced in the neural retina despite normal mRNA levels, confirming that CD147/basigin is required post-transcriptionally for MCT4 protein stability and/or membrane targeting in vivo.\",\n      \"method\": \"Immunofluorescence microscopy, Western blot, and RT-PCR in Bsg−/− knockout mice\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with multiple orthogonal readouts (protein vs. mRNA levels)\",\n      \"pmids\": [\"12601063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MCT4 mediates lactate/H+ efflux and is required for tumor glycolytic flux; zinc-finger nuclease knockout of MCT4 in LS174T colon adenocarcinoma cells reduced glycolytic flux and tumor growth, and MCT4 re-expression in respiration-deficient cells restored tumorigenicity.\",\n      \"method\": \"Zinc finger nuclease-mediated MCT4 knockout, inducible shRNA silencing, AR-C155858 MCT1/2 pharmacological inhibition, tumor xenograft growth assay, lactate secretion measurement\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic knockout and re-expression rescue, multiple cell line and in vivo validation\",\n      \"pmids\": [\"21930917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MCT4 silencing in renal clear cell carcinoma impairs lactate secretion, causes intracellular acidosis, reduces intracellular ATP, and induces cell-cycle arrest and apoptosis, establishing MCT4 as a functional regulator of the Warburg effect in this cancer.\",\n      \"method\": \"Genome-wide RNAi screen, siRNA knockdown in 8 ccRCC lines, lactate secretion assay, intracellular pH measurement, ATP quantification, flow cytometry (cell cycle and apoptosis)\",\n      \"journal\": \"The Journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-wide functional screen plus mechanistic validation with multiple phenotypic readouts across multiple cell lines\",\n      \"pmids\": [\"22362593\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SLC16A3/MCT4 promoter DNA methylation inversely regulates MCT4 expression in renal clear cell carcinoma; promoter activity assays in RCC cell lines confirmed that DNA methylation directly suppresses MCT4 transcription.\",\n      \"method\": \"Bisulfite sequencing, TCGA methylation analysis, promoter activity (luciferase) assays in RCC cell lines, mRNA and protein quantification\",\n      \"journal\": \"Clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — promoter reporter assays plus correlation validated in three independent cohorts; mechanism (writer) not fully defined\",\n      \"pmids\": [\"23881922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Under hypoxia, NF-κB (RelA/p65) represses ZBTB7A (encoding the repressor FBI-1), which normally binds FBI-1-response elements and HREs in the SLC16A3 promoter to suppress MCT4 transcription; loss of FBI-1 under hypoxia de-represses SLC16A3, while HIF-1α simultaneously activates it via an HRE.\",\n      \"method\": \"Transient transfection and luciferase reporter assays of SLC16A3 promoter, oligonucleotide pulldown, ChIP assays, siRNA knockdown of ZBTB7A and HIF-1α, NF-κB overexpression in colon cancer cells\",\n      \"journal\": \"Biochimica et biophysica acta. Gene regulatory mechanisms\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (ChIP, reporter, pulldown) but single lab\",\n      \"pmids\": [\"31271899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Hypoxia (1% O2 or DMOG treatment) induces MCT4 expression in cultured cortical astrocytes via HIF-1α; siRNA knockdown of HIF-1α prevented MCT4 induction, and MCT4 induction was necessary for increased lactate transport capacity and astrocyte survival under prolonged hypoxia.\",\n      \"method\": \"siRNA against HIF-1α, prolyl hydroxylase inhibitor DMOG, siRNA against MCT4, lactate release measurement, astrocyte survival assay under 1% O2\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA epistasis (HIF-1α → MCT4 → lactate transport) with functional survival readout; single lab\",\n      \"pmids\": [\"24375723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Nitric oxide induces MCT4 expression in astrocytes at mRNA and protein levels via a cGMP-independent transcriptional mechanism, increasing astrocytic lactate transport capacity; siRNA against MCT4 prevented the NO-induced increase in lactate transport.\",\n      \"method\": \"NO donor treatment, cGMP analog and guanylate cyclase inhibitor controls, siRNA against MCT4, lactate transport measurement, 24-h cumulative lactate release assay\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological epistasis plus siRNA rescue with functional readout; single lab\",\n      \"pmids\": [\"21901758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MCT4 histidine residue His382 in the extracellular loop is essential for pH regulation of MCT4-mediated lactate transport; H382A mutation abolished pH-dependent activity, and chemical modification of histidines (DEPC) removed pH regulation without fully inactivating transport.\",\n      \"method\": \"Site-directed mutagenesis (H382A), Xenopus oocyte expression system, DEPC chemical modification, Zn2+ inhibition, lactate uptake assay at varied pH\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — active-site mutagenesis with functional reconstitution in Xenopus oocyte system\",\n      \"pmids\": [\"25919709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Diclofenac is a non-competitive inhibitor of MCT4-mediated lactate transport with Ki ~20 µM, as demonstrated in Caco-2 cells (endogenously expressing MCT4) and validated in the Xenopus oocyte expression system.\",\n      \"method\": \"Lactate uptake inhibition assay in Caco-2 cells, kinetic analysis (inhibition constant), Xenopus oocyte expression system with MCT4\",\n      \"journal\": \"Drug metabolism and pharmacokinetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — kinetic characterization in two systems (endogenous and heterologous expression); single lab\",\n      \"pmids\": [\"27236641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Syrosingopine is a dual MCT1/MCT4 inhibitor (60-fold higher potency on MCT4) that prevents lactate and H+ efflux; MCT4 inhibition causes intracellular lactate accumulation leading to end-product inhibition of lactate dehydrogenase, reducing NAD+ regeneration from NADH and blocking glycolysis, which is synthetically lethal with metformin.\",\n      \"method\": \"Pharmacological inhibition with syrosingopine, intracellular lactate measurement, NAD+/NADH ratio, ATP measurement, exogenous NAD+ rescue, metformin combination lethality assay in cancer cells\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic pathway established with pharmacological inhibition, metabolite rescue, and multiple orthogonal readouts\",\n      \"pmids\": [\"30540938\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MCT4 in colonic epithelial cells promotes NF-κB p65 nuclear translocation and enhances NF-κB-CBP interaction while dissolving the CREB-CBP complex, thereby increasing IL-6 transcription and reducing CREB-mediated ZO-1 expression, disrupting intestinal barrier function.\",\n      \"method\": \"Lentiviral MCT4 overexpression, luciferase reporter assays for IL-6 and ZO-1 promoters, co-immunoprecipitation of NF-κB-CBP and CREB-CBP complexes, ChIP assay, in vivo colitis model with MCT4 inhibitor CHC\",\n      \"journal\": \"Cell proliferation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods (Co-IP, ChIP, reporter, in vivo) but single lab; non-metabolic MCT4 function\",\n      \"pmids\": [\"31418947\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"LKB1 loss enhances lactate production and secretion via MCT4, leading to M2 macrophage polarization and hypofunctional T cells; MCT4 knockout reversed immunotherapy resistance to PD-1 blockade in syngeneic murine models, and exogenous lactate recapitulated immunosuppression reversed by MCT4 knockdown.\",\n      \"method\": \"MCT4 knockout in murine tumor models, syngeneic PD-1 blockade tumor experiments, single-cell RNA profiling, GPR81 blockade, exogenous lactate treatment, MCT4 knockdown\",\n      \"journal\": \"Cancer cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO, rescue with exogenous lactate, GPR81 blockade epistasis, in vivo syngeneic immunotherapy model; multiple orthogonal approaches\",\n      \"pmids\": [\"37327788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"MCT4 deficiency in macrophages results in intracellular lactate accumulation leading to histone H3 lysine 18 lactylation (H3K18la), which activates transcription of anti-inflammatory genes and TCA cycle genes, promoting M1-to-M2 transformation and protecting against atherosclerosis.\",\n      \"method\": \"MCT4 gene manipulation and protein hydrolysis-targeted chimerism (PROTAC), histone lactylation assays (H3K18la ChIP), gene expression profiling, atherosclerosis mouse model\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic manipulation plus ChIP for lactylation mark; single lab but multiple approaches\",\n      \"pmids\": [\"38733581\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MCT4 mediates lactate-dependent stabilization and glycosylation of PD-L1 via the WNT pathway in triple-negative breast cancer cells; MCT4 knockout reduced extracellular lactate, and lactate treatment of MCT4-KO cells restored PD-L1 glycosylation.\",\n      \"method\": \"CRISPR/Cas9 MCT4 knockout, lentiviral MCT4 overexpression, exogenous lactate treatment, Western blot for PD-L1 glycosylation, multiple immunohistochemical staining\",\n      \"journal\": \"Journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — genetic KO and lactate rescue establish pathway; WNT mechanism not deeply validated; single lab\",\n      \"pmids\": [\"36199799\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MCT4 in hypothalamic tanycytes is required for metabolic signaling that regulates feeding behavior; adenoviral shRNA knockdown of MCT4 in the third ventricle decreased food intake and altered orexigenic neuropeptide responses to intracerebroventricular glucose.\",\n      \"method\": \"Adenovirus-mediated shRNA knockdown of MCT4 in rat third ventricle, food intake measurement, neuropeptide expression analysis, intracerebroventricular glucose administration\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo knockdown with defined behavioral and molecular phenotype; single lab\",\n      \"pmids\": [\"31578706\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MCT4 (and its chaperone CD147) are required for lactate export from Sertoli cells during spermatogenesis; cadmium exposure reduces MCT4 and CD147 protein levels and disrupts MCT4/CD147 co-localization at the cell membrane, thereby reducing lactate export.\",\n      \"method\": \"Co-localization fluorescence microscopy of MCT4-CD147 complex in mouse Sertoli cells, Western blot, mRNA analysis, extracellular/intracellular lactate measurement, LDH activity assay\",\n      \"journal\": \"Toxicology in vitro\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — co-localization without direct functional reconstitution; single lab, toxicology model\",\n      \"pmids\": [\"30615929\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PGC-1α overexpression in skeletal muscle specifically increases MCT1 (and its chaperone CD147) expression but not MCT4 or MCT2, establishing PGC-1α as a transcriptional regulator upstream of MCT1/CD147 in oxidative skeletal muscle.\",\n      \"method\": \"In vivo plasmid transfection of PGC-1α-pcDNA into rat muscle, Western blot for MCT1/MCT4/CD147, lactate uptake assay in transfected muscle, chronic stimulation model\",\n      \"journal\": \"Physiological genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo transfection with functional readout; single lab but multiple muscle models\",\n      \"pmids\": [\"18523157\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NF-κB/miR-425-5p/MCT4 axis mediates diabetic endothelial injury: NF-κB activation in high-glucose conditions increases miR-425-5p, which directly targets MCT4 mRNA, reducing MCT4 expression, causing intracellular lactate accumulation and apoptosis in endothelial cells.\",\n      \"method\": \"miR-425-5p target validation (MCT4 as direct target), NF-κB activation/inhibition, miR-425-5p overexpression in HUVECs, lactate accumulation measurement, apoptosis assay\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — miRNA target validation and pathway epistasis; single lab\",\n      \"pmids\": [\"31711985\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MCT4 (not MCT4's transport activity alone) promotes actin cytoskeleton reorganization, cell migration, and invasion in glioma cells; MCT4 overexpression enhanced these processes while MCT4 inhibition mitigated angiogenesis induction.\",\n      \"method\": \"Stable MCT4 overexpression and knockdown in F98 glioma cells, migration/invasion assays, actin cytoskeleton imaging, angiogenesis assay, organotypic brain slice model, extracellular lactate/pH measurement\",\n      \"journal\": \"Journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — loss- and gain-of-function with multiple cancer hallmark readouts; single lab\",\n      \"pmids\": [\"33936203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Global MCT4 knockout mice exhibit exercise intolerance and structural degeneration of neuromuscular junctions (NMJs) with decremented compound muscle action potentials, demonstrating that MCT4-mediated lactate export from glycolytic fibers is required for motor unit integrity.\",\n      \"method\": \"Global MCT4 knockout mice, treadmill exercise testing, compound muscle action potential recording in vivo, immunofluorescence of NMJ morphology, comparison with muscle-specific basigin conditional KO\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with in vivo electrophysiology and morphological phenotype; comparison with conditional KO distinguishes MCT4-specific effects\",\n      \"pmids\": [\"31837519\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MCT4 expression in Ras-transformed tumor cells in vivo markedly increases the pH gradient between intracellular and extracellular compartments (from 0.14 to 0.43 units), and genetic loss of MCT4 combined with NHE-1 deficiency caused tumor regression, establishing MCT4 as a primary proton/lactate co-transporter driving intracellular alkalinization in tumors.\",\n      \"method\": \"In vivo MRS measurement of intracellular/extracellular pH in tumor xenografts, isogenic CCL39 variants with MCT4 and/or NHE-1 genetic deficiency, tumor growth and necrosis measurement\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct in vivo pH measurement in genetically defined isogenic tumor variants; clean epistasis between MCT4 and NHE-1\",\n      \"pmids\": [\"21484790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Wounding of RPE monolayers causes dedifferentiation with loss of MCT3 and concomitant upregulation of MCT4 in migrating cells at the wound edge; re-epithelialization restores MCT3 expression, indicating that MCT4 expression marks the dedifferentiated/migratory state of RPE cells.\",\n      \"method\": \"Scratch wounding of chick RPE/choroid explants and human fetal RPE monolayers, immunofluorescence microscopy, Western blot for MCT3 and MCT4 during wound healing and re-epithelialization\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct imaging of MCT isoform switching with defined morphological context; single lab\",\n      \"pmids\": [\"20505202\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC16A3/MCT4 is a proton-coupled lactate symporter that requires CD147/basigin as a chaperone for plasma membrane targeting and activity; it is transcriptionally induced by hypoxia via HIF-1α (and de-repressed by NF-κB-mediated silencing of the repressor FBI-1/ZBTB7A), localizes to the sarcolemma and plasma membrane of glycolytic cells to mediate high-capacity lactate and H+ efflux (with a true Km for lactate of ~1 mM), and its activity sets intracellular pH, NAD+ regeneration capacity, and extracellular lactate levels that in turn regulate immune cell function, histone lactylation, NMJ integrity, and tumor growth.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SLC16A3 encodes MCT4, a proton-coupled monocarboxylate transporter that mediates high-capacity efflux of lactate and H⁺ from glycolytic cells, thereby maintaining intracellular pH homeostasis, sustaining NAD⁺ regeneration, and shaping the extracellular metabolic milieu. MCT4 requires the chaperone CD147/basigin for post-transcriptional stabilization and trafficking to the plasma membrane; without CD147, MCT4 protein is severely reduced despite normal mRNA levels [PMID:10921872, PMID:12601063]. Transcription of SLC16A3 is directly activated by HIF-1α via a hypoxia-response element in its promoter and further de-repressed under hypoxia through NF-κB–mediated downregulation of the transcriptional repressor ZBTB7A/FBI-1, while promoter DNA methylation provides an additional layer of epigenetic silencing [PMID:16452478, PMID:31271899, PMID:23881922]. Loss of MCT4 causes intracellular lactate accumulation that inhibits glycolysis, triggers histone lactylation-dependent transcriptional reprogramming in macrophages, impairs neuromuscular junction integrity in vivo, and—in tumors—restricts growth and restores sensitivity to immune checkpoint blockade [PMID:30540938, PMID:38733581, PMID:31837519, PMID:37327788].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that MCT4 cannot reach the plasma membrane alone resolved the question of why heterologous MCT4 expression often failed: CD147/basigin was identified as the obligate chaperone whose transmembrane domain physically interacts with MCT4 to enable surface delivery and transport activity.\",\n      \"evidence\": \"Reciprocal co-IP, chemical cross-linking, CD2-CD147 chimera mapping, and co-transfection reconstitution in mammalian cells\",\n      \"pmids\": [\"10921872\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Stoichiometry of the MCT4–CD147 complex was not determined\",\n        \"Whether other auxiliary subunits participate in trafficking remains open\",\n        \"Structural basis of the transmembrane interaction was not resolved\"\n      ]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Subcellular fractionation of skeletal muscle showed MCT4 is restricted to the sarcolemma (with an intracellular pool in triads/SR), distinguishing it from the dual sarcolemmal-mitochondrial localization of MCT1 and assigning MCT4 a dedicated plasma-membrane export role.\",\n      \"evidence\": \"Subcellular fractionation and isoform-specific Western blotting in rat skeletal muscle\",\n      \"pmids\": [\"10827010\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional significance of the triad/SR pool was not tested\",\n        \"No immunogold EM confirmation was provided\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"In vivo validation in basigin-null mice showed that CD147 is required post-transcriptionally for MCT4 protein stability, not just trafficking—MCT4 protein was severely depleted despite normal mRNA, extending the chaperone model from cell lines to intact tissue.\",\n      \"evidence\": \"Bsg−/− knockout mice with immunofluorescence, Western blot, and RT-PCR in neural retina\",\n      \"pmids\": [\"12601063\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether CD147 loss leads to proteasomal or lysosomal degradation of MCT4 was not determined\",\n        \"Rescue by CD147 re-expression was not performed\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Identification of a functional HRE in the SLC16A3 promoter directly bound by HIF-1α established the molecular basis for hypoxia-induced MCT4 upregulation, explaining why MCT4 is the predominant lactate transporter in hypoxic and glycolytic tissues.\",\n      \"evidence\": \"Promoter-luciferase reporters, HRE deletion/point mutation, gel-shift and supershift assays in hypoxic HeLa cells\",\n      \"pmids\": [\"16452478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Contribution of HIF-2α was not addressed\",\n        \"Chromatin context (histone modifications at the HRE) was not examined\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Functional studies in tumors demonstrated that MCT4 is a primary driver of intracellular alkalinization and lactate efflux required for tumor growth: MCT4 knockout reduced glycolytic flux, collapsed the pH gradient, and—combined with NHE-1 loss—caused tumor regression, while MCT4 re-expression rescued tumorigenicity in respiration-deficient cells.\",\n      \"evidence\": \"ZFN-mediated MCT4 KO in colon adenocarcinoma, in vivo MRS pH measurement in isogenic tumor variants, xenograft growth assays\",\n      \"pmids\": [\"21930917\", \"21484790\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether MCT4 loss selects for compensatory transporter upregulation in vivo was not examined\",\n        \"Immune microenvironment effects were not assessed in these xenograft (immunodeficient host) models\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Genome-wide RNAi screening in renal clear cell carcinoma independently confirmed MCT4 as essential for the Warburg effect, showing that MCT4 silencing causes intracellular acidosis, ATP depletion, cell-cycle arrest, and apoptosis, while promoter DNA methylation was identified as an epigenetic regulator of SLC16A3 expression.\",\n      \"evidence\": \"Genome-wide RNAi screen, siRNA across 8 ccRCC lines, intracellular pH/ATP/lactate assays; bisulfite sequencing and promoter-luciferase assays\",\n      \"pmids\": [\"22362593\", \"23881922\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The methyltransferase(s) responsible for SLC16A3 promoter methylation were not identified\",\n        \"Whether demethylation agents restore MCT4 and sensitize tumors was not tested in vivo\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Mutagenesis of His382 in the extracellular loop revealed the molecular basis for pH-dependent regulation of MCT4 transport, answering how extracellular acidification modulates lactate efflux kinetics.\",\n      \"evidence\": \"Site-directed mutagenesis (H382A), DEPC chemical modification, Zn²⁺ inhibition, Xenopus oocyte expression and uptake assays at varied pH\",\n      \"pmids\": [\"25919709\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No crystal or cryo-EM structure was available to place His382 in a three-dimensional context\",\n        \"Whether His382 regulation is conserved across MCT family members was not tested\"\n      ]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Pharmacological dual MCT1/MCT4 inhibition with syrosingopine revealed that blocking MCT4-dependent lactate export causes intracellular lactate accumulation sufficient to inhibit LDH and collapse NAD⁺ regeneration, establishing a metabolic vulnerability that is synthetically lethal with metformin.\",\n      \"evidence\": \"Syrosingopine treatment of cancer cells, intracellular lactate and NAD⁺/NADH measurements, exogenous NAD⁺ rescue, metformin combination lethality\",\n      \"pmids\": [\"30540938\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct binding site of syrosingopine on MCT4 was not mapped\",\n        \"In vivo pharmacokinetics and toxicity of syrosingopine–metformin combination were not established\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Revised kinetic analysis using intracellular FRET sensors corrected the MCT4 Km for lactate from ~30 mM to ~1 mM, fundamentally changing the understanding of MCT4 as a high-affinity rather than low-affinity transporter and explaining its efficacy even at modest intracellular lactate concentrations.\",\n      \"evidence\": \"FRET sensors (Laconic, Pyronic), CRISPR/Cas9 MCT4 deletion in MDA-MB-231 cells and macrophages, numerical simulation\",\n      \"pmids\": [\"31719150\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Km under physiological intracellular ionic conditions and with native CD147 stoichiometry remains to be confirmed in intact tissue\",\n        \"Pyruvate transport kinetics were less thoroughly validated\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"A second layer of transcriptional control was uncovered: NF-κB represses ZBTB7A/FBI-1, which normally occupies the SLC16A3 promoter at both FBI-1 response elements and HREs, so that hypoxia simultaneously activates HIF-1α and removes FBI-1 repression, providing a dual-input logic gate for MCT4 induction.\",\n      \"evidence\": \"ChIP, oligonucleotide pulldown, promoter-luciferase reporters, siRNA knockdown of ZBTB7A and HIF-1α in colon cancer cells\",\n      \"pmids\": [\"31271899\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether FBI-1 physically competes with HIF-1α for HRE occupancy or acts at distinct elements was not fully resolved\",\n        \"Single-lab finding; independent replication needed\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Global MCT4 knockout mice exhibited exercise intolerance and structural NMJ degeneration with decremented compound muscle action potentials, demonstrating that MCT4-mediated lactate export from glycolytic muscle fibers is essential for neuromuscular junction integrity in vivo.\",\n      \"evidence\": \"MCT4 global knockout mice, treadmill testing, in vivo electrophysiology, NMJ immunofluorescence, comparison with muscle-specific basigin conditional KO\",\n      \"pmids\": [\"31837519\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the NMJ defect is due to lactate/pH imbalance in the muscle fiber or loss of lactate signaling to Schwann cells/motor neurons was not distinguished\",\n        \"Rescue by MCT4 re-expression in specific cell types was not performed\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"MCT4-mediated tumor lactate export was shown to create an immunosuppressive microenvironment: MCT4 knockout reversed M2 macrophage polarization, restored T-cell function, and sensitized LKB1-mutant tumors to anti-PD-1 therapy, connecting metabolic transport directly to immune evasion.\",\n      \"evidence\": \"MCT4 KO in syngeneic murine tumor models, PD-1 blockade, single-cell RNA profiling, GPR81 blockade epistasis, exogenous lactate rescue\",\n      \"pmids\": [\"37327788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether MCT4 inhibition benefits immunotherapy in non-LKB1-mutant contexts was not tested\",\n        \"Selective MCT4 inhibitors suitable for clinical translation were not available\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"MCT4 deficiency in macrophages was found to drive intracellular lactate accumulation that promotes histone H3K18 lactylation, activating anti-inflammatory and TCA cycle gene programs—revealing a cell-intrinsic epigenetic mechanism by which MCT4 loss reprograms macrophage identity toward an M2-like state.\",\n      \"evidence\": \"MCT4 gene manipulation and PROTAC degradation in macrophages, H3K18la ChIP, gene expression profiling, atherosclerosis mouse model\",\n      \"pmids\": [\"38733581\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether lactylation-driven reprogramming occurs in other immune cell types was not tested\",\n        \"The writer enzyme for H3K18la in this context was not identified\",\n        \"Single-lab finding\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"No high-resolution structure of MCT4 (alone or in complex with CD147) has been determined, and no selective, clinically viable MCT4 inhibitor exists; the structural basis of substrate selectivity, the mechanism by which CD147 stabilizes MCT4, and whether MCT4 has non-transport (scaffolding) functions remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No cryo-EM or crystal structure of MCT4 or MCT4–CD147 complex\",\n        \"No selective MCT4 inhibitor with demonstrated in vivo efficacy and safety\",\n        \"Whether MCT4 has transport-independent signaling or scaffolding functions is unresolved\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [2, 5, 6, 11, 13, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [1, 3, 4, 23]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [2, 5, 6, 13, 24]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [2, 5, 11, 13]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 6, 15, 24]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [15, 16]}\n    ],\n    \"complexes\": [\n      \"MCT4–CD147/basigin complex\"\n    ],\n    \"partners\": [\n      \"BSG\",\n      \"HIF1A\",\n      \"ZBTB7A\",\n      \"SLC9A1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}